Invention Grant
- Patent Title: Oral tablet for delivery of active ingredients to the gastrointestinal tract
-
Application No.: US17344373Application Date: 2021-06-10
-
Publication No.: US11260030B2Publication Date: 2022-03-01
- Inventor: Helle Wittorff
- Applicant: Fertin Pharma A/S
- Applicant Address: DK Vejle
- Assignee: Fertin Pharma A/S
- Current Assignee: Fertin Pharma A/S
- Current Assignee Address: DK Vejle
- Agency: Forge IP, PLLC
- Main IPC: A61K9/20
- IPC: A61K9/20 ; A61K9/00 ; A61K31/734 ; A61K31/165 ; A61K31/43 ; A61K31/606 ; A61K31/708

Abstract:
An oral tablet for delivery of active ingredients to the gastrointestinal tract includes a population of particles and an active ingredient to be delivered to the gastrointestinal tract. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in induced saliva generation upon mastication of the tablet, wherein the tablet is designed to be masticated and designed to deliver the active ingredient to the gastrointestinal tract as part of the saliva generated upon mastication of the tablet.
Public/Granted literature
- US20210299052A1 Oral Tablet For Delivery Of Active Ingredients To The Gastrointestinal Tract Public/Granted day:2021-09-30
Information query